← Leaderboards
Kim A Margolin
University Of Southern California
$1,304,920
Attributed
$1,304,920
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $360.6K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$1,304,920 · 5
By mechanism
U10$1,136,855 · 1
M01$168,065 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Kathleen R Ell$9,983,182
- Louis Dubeau$6,576,174
- Derek Raghavan$1,863,220
- Veronica Wendy Setiawan$9,412,373
- Valerie Israel$885,479
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchCancer PreventionGrantBone Marrow TransplantationClinical TrialsFundingNeoplasm /Cancer ImmunotherapyNeoplasm /Cancer ChemotherapyInstitutionResearch PersonnelAbstractingCalendarCaliforniaCancer CareConceptCooperative Agreements, U-SeriesCytogeneticsCombination Cancer TherapyCaringClinical Trials, Phase IiiCitiesCommitBaseCancer Registry /Resource
Grant awards (10)
City of Hope Southwest Oncology Group Clinical Trials$326,504
U10 · FY2007 · CA · contact PI
City of Hope Southwest Oncology Group Clinical Trials$32,200
U10 · FY2007 · CA · contact PI
HIGH DOSE INTERLEUKIN-2 (IL-2) THERAPY IN "LYMPHODEPLETED PRIMED" PATIENTS WITH$1,939
M01 · FY2007 · RR · contact PI
City of Hope Southwest Oncology Group Clinical Trials$315,196
U10 · FY2006 · CA · contact PI
PHII: A PHASE II STUDY OF UCN-01 IN METASTATIC MELANOMA$2,178
M01 · FY2006 · RR · contact PI
City of Hope Southwest Oncology Group Clinical Trials$186,909
U10 · FY2005 · CA
PHII-42: A PHASE II TRIAL OF G3139 (GENASENSE) ANTI-BCL-2 ANTISENSE OLIGON$115,845
M01 · FY2005 · RR
PHII: A PHASE II STUDY OF UCN-01 IN METASTATIC MELANOMA$1,032
M01 · FY2005 · RR
City of Hope Southwest Oncology Group Clinical Trials$276,046
U10 · FY2004 · CA
PHII-42: A Phase II Trial of G3139 (Genasense)$47,071
M01 · FY2004 · RR